AQR Capital Management LLC Acquires 25,467 Shares of Avanos Medical, Inc. (NYSE:AVNS)

AQR Capital Management LLC increased its holdings in shares of Avanos Medical, Inc. (NYSE:AVNS) by 21.0% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 146,983 shares of the company’s stock after buying an additional 25,467 shares during the quarter. AQR Capital Management LLC owned 0.32% of Avanos Medical worth $2,875,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of the business. Caxton Associates LP lifted its position in shares of Avanos Medical by 13.6% during the 2nd quarter. Caxton Associates LP now owns 17,035 shares of the company’s stock worth $339,000 after buying an additional 2,034 shares during the last quarter. Magnetar Financial LLC bought a new stake in shares of Avanos Medical during the 2nd quarter worth $248,000. Public Sector Pension Investment Board lifted its position in shares of Avanos Medical by 6.1% during the 2nd quarter. Public Sector Pension Investment Board now owns 100,957 shares of the company’s stock worth $2,011,000 after buying an additional 5,793 shares during the last quarter. Canada Pension Plan Investment Board bought a new stake in shares of Avanos Medical during the 2nd quarter worth $70,000. Finally, XTX Topco Ltd bought a new stake in shares of Avanos Medical during the 2nd quarter worth $202,000. 95.17% of the stock is currently owned by institutional investors.

Avanos Medical Price Performance

Shares of AVNS stock opened at $22.58 on Tuesday. The company has a quick ratio of 1.49, a current ratio of 2.28 and a debt-to-equity ratio of 0.13. The company has a market cap of $1.04 billion, a P/E ratio of -16.98 and a beta of 0.91. Avanos Medical, Inc. has a twelve month low of $17.24 and a twelve month high of $25.36. The business has a fifty day simple moving average of $23.54 and a 200 day simple moving average of $21.17.

Avanos Medical (NYSE:AVNS) last posted its earnings results on Wednesday, July 31st. The company reported $0.34 EPS for the quarter, beating the consensus estimate of $0.29 by $0.05. The firm had revenue of $171.70 million during the quarter, compared to the consensus estimate of $170.67 million. Avanos Medical had a return on equity of 4.48% and a net margin of 1.13%. The business’s quarterly revenue was up 1.4% on a year-over-year basis. During the same period last year, the company earned $0.24 earnings per share. On average, sell-side analysts forecast that Avanos Medical, Inc. will post 1.39 EPS for the current fiscal year.

Avanos Medical Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.